NASDAQ:OMCL#1 of 5 in this industry1 market
Omnicell
Revenue$1.2Bfrom a sourced record
Markets named in1across this research
Incumbent in0the one to displace
Rank in industry1 / 5by revenue
01
Where it competes
Every market in this research that names Omnicell. Where it is the named incumbent it leads the list. The entry signal is the market’s, not the company’s — it says how open that market is to someone new.
| Market | Role | Share | Entry signal |
|---|---|---|---|
| Independent Pharmacy Management 456110 Pharmacies and drug stores |
Competitor | — | 42% entry signal |
02
Others in Pharmacies and drug stores
Ranked by revenue. Companies that disclose none follow, ordered by how many markets name them.
| 1 | Omnicell NASDAQ:OMCL | $1.2B |
| 2 | Liberty Private | — |
| 3 | McKesson EnterpriseRx Private | — |
| 4 | PioneerRx Private | — |
| 5 | QS Private | — |
Company details are from the search.cos database (snapshot 2026-10-10); market roles, shares and sourced revenue are from the research records linked above. Filed under the industry it serves — a software vendor sits with the industry that buys from it. Ranks convert currencies at approximate rates to put companies in order; every figure shown is in the currency it was reported in.